Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
NEJM study shows strong protection across strains
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
The standout story remains Wegovy, particularly its new oral formulation
Subscribe To Our Newsletter & Stay Updated
